Ashenafi Shumey Cherkos

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Mycobacterium Tuberculosis

Top Venues

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ashenafi Shumey Cherkos, Sylvia M LaCourse, Daniel A Enquobahrie, Jaclyn N Escudero, Jerphason Mecha, Daniel Matemo, John Kinuthia, Sarah J Iribarren, Grace C John-Stewart
Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial. PloS one 19 (8) (2024)
Ashenafi Shumey Cherkos, Sylvia M LaCourse, Daniel A Enquobahrie, Jaclyn N Escudero, Jerphason Mecha, Daniel Matemo, John Kinuthia, Sarah J Iribarren, Grace C John-Stewart
Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial. PloS one 19 (8) (2024)
Ashenafi Shumey Cherkos, Sylvia M LaCourse, Daniel A Enquobahrie, Jaclyn N Escudero, Jerphason Mecha, Daniel Matemo, John Kinuthia, Sarah J Iribarren, Grace C John-Stewart
Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial. PloS one 19 (8) (2024)
Ashenafi Shumey Cherkos, Sylvia M LaCourse, Daniel A Enquobahrie, Jaclyn N Escudero, Jerphason Mecha, Daniel Matemo, John Kinuthia, Grace John-Stewart
Isoniazid preventive therapy during infancy does not adversely effect growth among HIV-exposed uninfected children: secondary analysis of data from a randomized controlled trial. medRxiv : the preprint server for health sciences (2023)